Navigation Links
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Date:10/22/2007

ificity about their questions and the potential impact, if any, on our timeline, we will provide an update."

The company is also reiterating guidance that it expects to commercialize Custom NX in Europe in the second half of 2008.

About the CUSTOM Trials

The CUSTOM I trial is a 30-patient first-in-man study designed to evaluate the preliminary safety and feasibility of in-situ stent customization. CUSTOM I's positive eight-month clinical results have been sustained at two years with no new MACE events, zero restenosis and no late stent thrombosis.

The CUSTOM II trial is a 100-patient study designed to evaluate the safety and efficacy of Custom NX for the treatment of long and multiple lesions. Of the 100 patients enrolled, 69 patients were enrolled in the long-lesion arm, and 31 patients were enrolled in the two-lesion arm of the study. CUSTOM II enrolled one of the most difficult to treat patient populations ever studied in a DES trial. In the CUSTOM II patient population, the average vessel diameter was 2.57mm and the average lesion length was 28.7mm. Twenty-six percent of the study participants were diabetic. The percentage of patients with ACC/AHA lesion grade B2 or C was 65.1 percent. CUSTOM II's six-month clinical results have been sustained at one year. The target lesion revascularization rate remained constant at four percent, with no new MACE events, and no late stent thrombosis.

The company's CUSTOM III clinical trial completed enrollment in July as previously announced, and the company expects the first available data to be presented at the 2008 Euro-PCR meeting.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to customize the length and diameter of the stent at the site of the lesion. The system features a proprietary modular stent de
'/>"/>

SOURCE XTENT, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Hologic, Inc. (Hologic or the Company) (NASDAQ: ... and supplier of premium diagnostics, medical imaging systems ... the healthcare needs of women, today announced that ... clinical practice comparing breast cancer screening with Hologic,s ... mammography alone showed a significant reduction in recall ...
(Date:5/23/2013)...   Direct to implant, or "one step," ... option for many women with BRCA (BReast CAncer) ... cancer risk, or with breast cancer. Traditionally, post-mastectomy ... second surgery to insert permanent implants, but immediate ... mastectomy can be a medically and cosmetically effective ...
(Date:5/23/2013)... May 23, 2013  Net Medical Xpress Solutions, Inc., ... announced today the company has signed a letter of ... based in Huntsville, AL . MedTel ... the staffing and recruitment of telemedicine physicians. Consideration for ... final agreement, which is expected by June 30, 2013. ...
Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... Target Enrollment Expected in Fourth Quarter, BERKELEY ... GNTA ) announced that the Data Safety Monitoring ... Genasense (oblimersen sodium),Injection, which is the Company,s lead ... as originally planned after initial review of,blinded safety ...
... unique Ranexa(R) mechanism of action -, CHICAGO, March ... today that ranolazine significantly (p<0.001),shortened the QT interval of ... LQT3, which is caused by a genetic mutation in ... rhythm problems, including,sudden death. Ranolazine also shortened cardiac relaxation ...
Cached Medicine Technology:DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 2Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 3
(Date:5/25/2013)... Beach, California (PRWEB) May 25, 2013 ... respectfully honoring those who have died serving our Country, ... work with prolonged partying and recklessness. The DUI attorneys ... Day Weekend DUI checklist to help keep this weekend’s ... Traffic Records System , there were more than 950 ...
(Date:5/25/2013)... 25, 2013 Communities of Distinction TV ... is the fifth largest media market in the United States ... one visitor destination in Texas and a major convention city. ... American West as it is home to many major museums. ... from sports to the arts. Residents and locals will be ...
(Date:5/25/2013)... May 25, 2013 The report ... By Types, Functions, Applications, Ingredients, Shell Materials, Packaging, ... the global food encapsulation market with analysis and ... It also identifies the driving and restraining factors ... of trends, opportunities, and challenges. The market is ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 According ... Emergency Management Market, 2013–2018", published by MarketsandMarkets is ... a CARC of 5.54% which analyzes and studies ... North America, Europe, Asia, and Rest of the ... Market Data Tables , 87 Figures ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4
... it out loud, CHICAGO, May 1 With ... a mental health challenge at any,one time, a new ... health and to empower those living with a mental ... to promote good mental health for,every child and adult ...
... 1 The following media,advisory was issued today ... Buerhaus, PhD, RN, FAAN, Professor of Nursing and ... Center, Nashville, TN; Karen Donelan, EdM, ScD, Senior,Scientist ... MA; Beth Ulrich, EdD, RN, FACHE, FAAN, Senior ...
... vision angle, researcher says , , THURSDAY, May 1 (HealthDay ... vision and reduce macular swelling caused by blockages in ... to researchers at the Johns Hopkins Wilmer Eye Institute. ... and some require several injections, but the results are ...
... Delaware County, nearly 24,000 adults under the age of ... the Senate approves,Pennsylvania Access to Basic Care, Health Secretary ... uninsured Pennsylvania citizens would have,greatly needed access to affordable ... perfect time to talk about reforming,health care in Pennsylvania," ...
... of Uninsured are Working, Struggling to Make Ends Meet, ... communities who are struggling with the rising costs of ... approves a bill to provide,health care insurance for all, ... visit to the Westmoreland County Food Bank, Deputy Secretary,of ...
... Event at Wal-Mart Stores Nationwide Receive ... Free Book, ... their families about living healthier, Speaking of,Women,s Health will hold its annual Community ... a.m. to 4 p.m. In,time for Mother,s Day, this event honors the "Everyday ...
Cached Medicine News:Health News:Making It Easier to Talk About Mental Health 2Health News:Making It Easier to Talk About Mental Health 3Health News:Making It Easier to Talk About Mental Health 4Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2Health News:Ranibizumab Injections Reduce Retinal Swelling 2Health News:State Health Secretary Visits City of Chester for 'Cover the Uninsured' Week 2Health News:Pennsylvania Agriculture Official Says Passage of PA ABC Crucial to Rural Communities 2Health News:Speaking of Women's Health Gives the Gift of Knowledge and Good Health This Mother's Day 2Health News:Speaking of Women's Health Gives the Gift of Knowledge and Good Health This Mother's Day 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: